Immuneering CorporationIMRXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
7.33%
↑ 115% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthAccelerating
Average
-48.26%
Historical baseline
PeriodValue
20257.33%
2024-9.69%
2023-12.89%
2022-52.70%
2021-98.37%
2020-171.54%
20190.00%